• Anthony Koupparis, Christian Villeda-Sandoval, Nicola Weale, Motaz El-Mahdy, David Gillatt, and Edward Rowe.
• Bristol Urological Institute, North Bristol NHS Trust, Southmead Hospital, Bristol, UK.
• BJU Int. 2015 Dec 1; 116 (6): 924-31.

ObjectivesTo assess the impact of the introduction of robot-assisted radical cystectomy (RARC) on an established enhanced recovery programme (ERP) and to examine the effect on mortality and morbidity rates, transfusion rates, and length of stay (LOS).Patients And MethodsData on 102 consecutive patients undergoing RARC with full intracorporeal reconstruction were obtained from our prospectively updated institutional database. These data were compared to previously published retrospective results from three separate groups of patients undergoing open radical cystectomy (ORC) at our centre. Our primary focus was perioperative outcomes including transfusion rate, complication rates, 30- and 90-day mortality rates, and LOS.ResultsThe demographics of the comparative groups showed no significant difference in age, gender distribution, and American Society of Anesthesiologists grade. A significant reduction in transfusion rate was seen in RARC vs ORC (P < 0.001). The median LOS for the RARC group was 8 vs 13 days for the ORC group (P < 0.001). There was trend to a lower total complication rate (48% vs 31%). The 30- and 90-day mortality rates were equivalent between the groups (2%).ConclusionsIntroduction of RARC and intracorporeal reconstruction represents the single biggest impact on our ERP, with significant reduction in transfusion rates and LOS, and a trend towards a lower complication rate.© 2015 The Authors BJU International © 2015 BJU International Published by John Wiley & Sons Ltd.

30 keywords...

hide…